Authors

Latest:

Dr. O'Reilly on Veliparib/Chemotherapy Triplet in Germline BRCA/PALB2+ Pancreatic Cancer

Eileen M. O’Reilly, MD, discusses the randomized phase II trial of gemcitabine and cisplatin versus gemcitabine and cisplatin and veliparib in patients with pancreas adenocarcinoma harboring a known germline BRCA or PALB2 mutation, which was presented at the 2020 Gastrointestinal Cancers Symposium.

Eileen M. O'Reilly, MD, Memorial Sloan Kettering Cancer Center

Eileen O'Reilly

Latest:

Dr O'Reilly on Survival Outcomes of the NAPOLI 3 trial in Metastatic PDAC

Eileen M. O'Reilly, MD, discusses survival outcomes from the phase 3 NAPOLI 3 trial in patients with metastatic pancreatic ductal adenocarcinoma.

Eileen O'Reilly, M

Latest:

Dr. O'Reilly on the Potential Role of Veliparib in Pancreatic Cancer

Eileen O'Reilly, MD, discusses the potential role of veliparib in pancreatic cancer.

Eileen O'Reilly, MD

Latest:

Dr. O'Reilly on the Role of Germline Testing in Pancreatic Cancer

Eileen O'Reilly, MD, discusses germline testing in pancreatic cancer.

Eileen O’Reilly, MD, Memorial Sloan-Kettering Cancer Center

Eileen O'Reilly, MD, MKSCC

Eilon Kirson, MD, PhD

Latest:

Dr. Kirson Discusses the LUNAR Study in Advanced NSCLC

Eilon Kirson, MD, PhD, chief medical officer, Novocure, discusses the LUNAR study in advanced non–small cell lung cancer.

Elaine Chang, MD

Latest:

Emerging Adulthood: From Adolescent to Attending Physician

Faced with a persistent question from her teenage years, Elaine Chang, MD, may have come up with an answer.

Elaine R. Mardis, PhD

Latest:

Elaine Mardis on Sensitivity to Aromatase Inhibitors

Elaine Mardis, from the Genome Institute at Washington University School of Medicine, on Sensitivity to Aromatase Inhibitors

Elaine Shum, MD

Latest:

Dr. Shum on Emerging Targeted Therapies in EGFR-Mutant NSCLC

Elaine Shum, MD, discusses emerging targeted therapies in EGFR-mutant non–small cell lung cancer.

Eleanor M. Walker, MD

Latest:

Dr. Walker on the Use of Radiation Therapy in Patients With Breast Cancer

Eleanor M. Walker, MD, senior staff physician, division director, Breast Services in the Department of Radiation Oncology, Henry Ford Cancer Institute, discusses the use of radiation therapy in patients with breast cancer.

Electra D. Paskett, PhD

Latest:

Electra D. Paskett, PhD, on Cervical Cancer Screening

Electra D. Paskett, PhD, Professor, College of Medicine, The Ohio State University, discusses the use of vinegar as a cervical cancer screening tool in the U.S.

Eleftheria Kalogera, MD, MSc

Latest:

Dr. Kalogera on Bowel Preparation Following Minimally Invasive or Open Hysterectomies

Eleftheria Kalogera, MD, MSc, instructor in Obstetrics and Gynecology, fellow in Gynecologic Oncology, in the department of Obstetrics and Gynecology, at Mayo Clinic College of Medicine, discusses the controversial topic of bowel preparation following minimally invasive or open hysterectomies.

Eleftherios P. Mamounas, MD

Latest:

Dr Mamounas on Surgical De-Escalation Strategies in HER2+ Breast Cancers

Terry P. Mamounas, MD, discusses surgical de-escalation strategies in the treatment of patients with HER2-positive breast cancer.

Eleftherios P. Mamounas, MD, University Florida

Eleftherios (Terry) P. Mamounas, MD

Latest:

Dr Mamounas on Key Advancements in the Use of Locoregional Therapy in Breast Cancer

Terry P. Mamounas, MD, discusses key advancements in the use of locoregional therapy for patients with breast cancer.

Elena Lukina, MD

Latest:

Dr. Lukina Discusses Timely Gaucher Disease Diagnosis

Dr. Elena Lukina Discusses Timely Gaucher Disease Diagnosis

Elena S. Ratner, MD, Yale University School of Medicine

Eleni Andreopoulou, MD

Latest:

Dr. Andreopoulou on the Impact of Immunotherapy in TNBC

Eleni Andreopoulou, MD, associate professor of clinical medicine, Weill Cornell Medical College, associate attending physician, NewYork-Presbyterian Hospital, discusses shifts in the treatment paradigm of metastatic triple-negative breast cancer (TNBC) and the impact immunotherapy has had in the field.